参考文献/References:
[1] KRAUS V B,HARGROVE D E,HUNTER D J,et al.Establishment of reference intervals for osteoarthritis-related soluble biomarkers:the FNIH/OARSI OA Biomarkers Consortium[J].Ann Rheum Dis,2017,76(1):179-185.
[2] JOSEPH G B,NEVITT M C,MCCULLOCH C E,et al.Associations between molecular biomarkers and MR-based cartilage composition and knee joint morphology:data from the osteoarthritis initiative[J].Osteoarthritis Cartilage,2018,26(8):1070-1077.
[3] GERMASCHEWSKI F M,MATHENY C J,LARKIN J,et al.Quantitation of ARGS aggrecan fragments in synovial fluid,serum and urine from osteoarthritis patients[J].Osteoarthritis and Cartilage 2014,22(5):690-697.
[4] SASAKI E,TSUDA E,YAMAMOTO Y,et al.Serum hyaluronic acid concentration predicts the progression of joint space narrowing in normal knees and established knee osteoarthritis-a five-year prospective cohort study[J].Arthritis Res Ther,2015,17(1):1-10.
[5] LENNEROV T,KAREL PAVELKA K,ENOLT L.Biomarkers of hand osteoarthritis[J].Rheumatol Int,2018,38(5):725-735.
[6] ASLAM I,PERJAR I,SHI X A,et al.Associations between biomarkers of joint metabolism,hand osteoarthritis,and hand pain and function:the johnston county osteoarthritis project[J].J Rheumatol,2014,41(5):938-944.
[7] MA T,ZHANG Z,SONG X,et al.Combined detection of COMP and CS846 biomarkers in experimental rat osteoarthritis:a potential approach for assessment and diagnosis of osteoarthritis[J].J Orthop Surg Res,2018,13(1):1-9.
[8] DOU X,ZHANG Z,WANG S,et al.Combined use ofserum miR-338-3p,cartilage oligomeric matrix protein and chondroitin sulfate-846 in the early diagnosis of knee osteoarthritis[J].Clin Lab,2019,65(3):319-324.
[9] GABUSI E,PAOLELLA F,MANFERDINI C,et al.Cartilage and bone serum biomarkers as novel tools for monitoring knee osteochondritis dissecans treated with osteochondral scaffold[J].Biomed Res Int,2018:9275102.
[10] TOMONAGA A,TAKAHASHI T,TANAKA Y T,et al.Evaluation of the effect of salmon nasal proteoglycan on biomarkers for cartilage metabolism in individuals with knee joint discomfort:a randomized double-blind placebo-controlled clinical study[J].Exp Ther Med,2017,14(1):115-126.
[11] NAGAOKA I,TSURUTA A,YOSHIMUR M.Chondroprotective action of glucosamine,a chitosan monomer,on the joint health of athletes[J].Int J Biol Macromol,2019,132:795-800.
[12] AZUKIZAWA M,ITO H,HAMAMOTO Y,et al.The effects of well-rounded exercise program on systemic biomarkers related to cartilage metabolism[J].Cartilage,2018,10(4):451-458.
[13] KRAUS V B,COLLINS J E,HARGROVE D,et al.Predictive validity of biochemical biomarkers in knee osteoarthritis:data from the FNIH OA biomarkers consortium[J].Ann Rheum Dis,2017,76(1):186-195.
[14] LUO Y,HE Y,REKER D,et al.A novel high sensitivity type Ⅱ collagen blood-based biomarker,PRO-C2,for assessment of cartilage formation[J].Int J Mol Sci,2018,19(11):3485.
[15] LIAN W,LIU H,SUN L Y,et al.Serum levels of PⅡCP,PⅡANP,and PⅡBNP are decreased in patients with an endemic osteochondropathy,Kashin-Beck disease[J].J Orthop Surg Res,2018,13(1):128.
[16] BIHLET A R,BYRJALSEN I,BAY-JENSEN A C,et al.Associations between biomarkers of bone and cartilage turnover,gender,pain categories and radiographic severity in knee osteoarthritis[J].Arthritis Res Ther,2019,21(1):203.
[17] ROTTERUD J H,REINHOLT F P,BECKSTROM K J,et al.Relationship between CTX-Ⅱ and atient characteristics,patient-reported outcome,muscle strength,and rehabilitation in patients with a focal artilage lesion of the knee:A prospective exploratory cohort study of 48 patients[J].BMC Musculoskelet Disord,2014,15:99.
[18] BJERRE-BASTOS J,BAY-JENSEN A C,KARSDAL M,et al.Biomarkers of bone and cartilage turnover CTX-I and CTX-Ⅱ predict total joint replacements in osteoarthritis [J].Osteoarthritis Cartilage,2019,27(S31):12-19.
[19] KUMAHASHI N,SWARD P,LARSSON S,et al.Type Ⅱ collagen C2C epitope n human synovial fluid and serum after knee injury-associations with molecular and structural markers of injury [J].Osteoarthritis Cartilage,2015,23(9):1506-1512.
[20] HE G,CHEN X,ZHANG G,et al.Detection of urine C2C and trace element level in patients with knee osteoarthritis[J].Cell Biochem Biophys,2014,70(1):475-479.
[21] POOLE A R,HA N,BOURDON S,et al.Ability of a urine assay of type Ⅱ collagen cleavage by collagenases to detect early onset and progression of articular cartilage degeneration:results from a population-based cohort study[J].J Rheumatol,2016,43(10):1864-1870.
[22] KONG S Y,STABLER T V,CRISCIONE L G,et al.Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis[J].Arthritis Rheum,2006,54(8):2496-2504.
[23] CHU C R,SHETH S,ERHART-HLEDIK J C,et al.Mechanically stimulated biomarkers signal cartilage changes over 5 years consistent with disease progression in medial knee osteoarthritis patients[J].J Orthop Res,2018,36(3):891-897.
[24] BAY-JENSEN A C,LIU Q,BYRJALSEN I,et al.Enzyme-linked immunosorbent assay(ELISAs)for metalloproteinase derived type Ⅱ collagen neoepitope,CⅡM-increased serum CⅡM in subjects with severe radiographic osteoarthritis[J].Clin Biochem,2011,44(5/6):423-429.
[25] SIEBUHR A S,PETERSEN K K,ARENDT-NIELSEN L,et al.Identification and characterisation of osteoarthritis patients with inflammation derived tissue turnover[J].Osteoarthritis Cartilage,2014,22(1):44-50.
[26] HICK A C,FONCK M,COSTES B,et al.Serum levels of Coll2-1,a specific biomarker of cartilage degradation,are not affected by sampling conditions,circadian rhythm,seasonality and physical activity[J].Cartilage,2021,13(1):540-549.
[27] STANCKER T G,VIEIRA S S,SERRA A J,et al.Can photobiomodulation associated with implantation of mesenchymal adipose-derived stem cells attenuate the expression of MMPs and decrease degradation of type Ⅱ collagen in an experimental model of osteoarthritis? [J].Lasers Med Sci,2018,33(5):1073-1084.
[28] WEI X,YIN K,LI P,et al.Type Ⅱ collagen fragment HELIX-Ⅱ is a marker for early cartilage lesions but does not predict the progression of cartilage destruction in human knee joint synovial fluid[J].Rheumatol Int,2013,33(7):1895-1899.
[29] KALA? E,BAHLOUS A,BOUZID K,et al.The role of type Ⅱ collagen fragments and X-ray progression of knee osteoarthritis[J].Ann Bio Clin,2014,72(6):715-721.
[30] SONG Q Q,SUN L Y,LI C H,et al.The urinary levels of CTX-Ⅱ,C2C,PYD,and Helix-Ⅱ increased among adults with KBD:a cross-sectional study[J].J Orthop Surg Res,2019,14(1):328.
[31] BOETH H,RAFFALT P C,MACMAHON A,et al.Association between changes in molecular biomarkers of cartilage matrix turnover andchanges in knee articular cartilage:a longitudinal pilot study[J].J Exp Orthop,2019,6(1):19.
[32] KUMM J,TAMM A,LINTROP M,et al.The value of cartilage biomarkers in progressive knee osteoarthritis:cross-sectional and 6-year follow-up study in middle-aged subjects[J].Rheumatol Int,2013,33(4):903-911.
[33] KLUZEK S,BAY-JENSEN A C,JUDGE A,et al.Serum cartilage oligomeric matrix protein and development of radiographic and painful knee osteoarthritis:a community-based cohort of middle-aged women[J].Biomarkers,2015,20(8):557-564.
[34] RIEGGER J,REHM M,BüCHELE G,et al.Serum cartilage oligomeric matrix protein in late-stage osteoarthritis:association with clinical features,renal function,and cardiovascular biomarkers[J].J Clin Med,2020,9(1):268.
[35] V??N?NEN T,VUOLTEENAHO K,KAUTIAINEN H,et al.NEORACo Study Group:Glycoprotein YKL40:a potential biomarker of disease activity in rheumatoid arthritis during intensive treatment with csDMARDs and infliximab.Evidence from the randomised controlled NEORACo trial[J].PLoS One,2017,12(8):e0183294.
[36] WANG P,SONG J,QIAN D.CTX-Ⅱ and YKL-40 in early diagnosis and treatment evaluation of osteoarthritis[J].Exp Ther Med,2019,17(1):423-431.
[37] HENROTIN Y,GHARBI M,MAZZUCCHELLI G,et al.Fibulin 3 peptides Fib3-1 and Fib3-2 are potential biomarkers of osteoarthritis[J].Arthritis Rheum,2012,64(7):2260-2267.
[38] DE VISSER H M,SANCHEZ C,MASTBERGEN S C,et al.Fib3-3 as a biomarker for osteoarthritis in a rat model with metabolic dysregulation[J].Cartilage,2019,10(3):329-334.
[39] RUNHAAR J,SANCHEZ C,TARALLA S,et al.Fibulin-3 fragments are prognostic biomarkers of osteoarthritis incidence in overweight and obese women[J].Osteoarthritis Cartilage,2016,24(4):672-678.
[40] KOPEC-MEDREK M,KUCHARZ E J.Fibulin-3 and other cartilage metabolism biomarkers in relationship to calprotectin(MRP8/14)and disease activity in rheumatoid arthritis patients treated with anti-TNF therapy[J].Adv Clin Exp Med,2018,27(3):383-389.
[41] 韩煜,张志星,边青山,等.膝骨关节炎中医证候血清生物标志物研究[J].中国中医骨伤科杂志,2014,22(12):8-12.